openPR Logo
Press release

Nuclear Medicine Market | Ongoing Trends and Recent Developments | Major Key Players like Cardinal Health (US), GE Healthcare (US), Curium (France), Bayer (Germany)

08-07-2019 08:27 AM CET | Health & Medicine

Press release from: MarketsandMarkets

Nuclear Medicine Market

Nuclear Medicine Market

Increasing incidence & prevalence of cancer and cardiovascular diseases and initiatives to lessen the demand-supply gap of Mo-99 are the key factors propelling the growth of this Nuclear Medicine Market. The Radiopharmaceuticals Market is expanding with the emergence of new applications and discovery of new medical isotopes. Nuclear Medicine is used in many diagnostic and therapeutic applications such as oncology, cardiology, neurology and other applications.

What the Market Looks Like?

Predicted to grow at a CAGR of 5.9% during the forecast period, the global Radiopharmaceuticals Market is estimated to reach $5.26 billion by the end of 2023. In 2018, North America dominated the market

Based on type, the Nuclear Medicine Market is segmented into diagnostic radiopharmaceuticals and therapeutic radiopharmaceuticals. Diagnostic radiopharmaceuticals have been further segmented into SPECT and PET radiopharmaceuticals. SPECT radiopharmaceuticals include Tc-99m, Tl-201, Ga-67, I-123, and other SPECT isotopes. In 2017, the Tc-99m segment accounted for the largest share of the nuclear medicine SPECT Radiopharmaceuticals Market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=417

The major application areas of PET nuclear medicine include oncology, cardiology, neurology, and others. The oncology segment is projected to account for the largest share of the PET Nuclear Medicine Market during the forecast period. The large share of this segment can be attributed to the use of F-18 which is a key isotope used in oncology applications. It is used to analyze glucose metabolism in the heart, lungs, and brain, which aids in cancer diagnosis.

What Drives the Nuclear Medicine Market?

The growth of the global market for Radiopharmaceuticals is primarily influenced by the following factors:

• Increasing Incidence and Prevalence of Target Conditions
• Alpha Radioimmunotherapy-Based Targeted Cancer Treatment
• Initiatives to Lessen the Demand-Supply Gap of Mo-99
• Use of Radiopharmaceuticals in Neurological Applications

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=417

Geographical growth scenario of Nuclear Medicine Market:

North America is expected to account for the largest share of the Nuclear Medicine Market in 2018, followed by Europe. The large share of this region can be attributed to the development of novel technologies for radioisotope production, government funding, and company initiatives in the region.

Leading Radiopharmaceuticals Market players and strategies adopted:

The prominent players in the Radiopharmaceuticals Market include Cardinal Health (US), GE Healthcare (US), and Curium (France) are the key players in the nuclear medicine. Other players involved in this market are Bayer (Germany), Lantheus Medical Imaging (US), Advanced Accelerator Applications (France), and Jubilant Life Sciences (India).

Read More in Detailed: https://www.marketsandmarkets.com/PressReleases/radiopharmaceuticals.asp

Cardinal Health dominated the global Nuclear Medicine Market in 2017. Cardinal Health is a healthcare services company providing pharmaceutical and medical products and services to healthcare providers. Cardinal Health operates in the US, Canada, the British Virgin Islands, Malaysia, Singapore, the UK, Luxembourg, Thailand, Switzerland, Ireland, and Belgium through its 150 subsidiaries.

Contact Us:

Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com

About MarketsandMarkets™:

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Nuclear Medicine Market | Ongoing Trends and Recent Developments | Major Key Players like Cardinal Health (US), GE Healthcare (US), Curium (France), Bayer (Germany) here

News-ID: 1819036 • Views:

More Releases from MarketsandMarkets

Transplant Diagnostics Market worth $6.8 million by 2028: Enabling Personalized Transplantation Approaches
Transplant Diagnostics Market worth $6.8 million by 2028: Enabling Personalized …
Transplant Diagnostics market was a rapidly growing sector within the healthcare industry. Transplant diagnostics involves a set of tests and procedures performed to assess the compatibility between a donor and recipient before organ or tissue transplantation. These tests are crucial to ensure successful transplant outcomes and minimize the risk of rejection. Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=2531061&utm_source=Openpr&utm_campaign=Paid&utm_content=Referral Transplant Diagnostics Market in terms of revenue was estimated to be worth $4.4 billion in 2022
Primary Cells Market worth $2.8 billion by 2028 | Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Lonza Group (Switzerland), Cell Biologics, Inc. (US)
Primary Cells Market worth $2.8 billion by 2028 | Thermo Fisher Scientific, Inc. …
Primary Cells Market in terms of revenue was estimated to be worth $1.7 billion in 2023 and is poised to reach $2.8 billion by 2028, growing at a CAGR of 10.5% from 2023 to 2028 according to a new report by MarketsandMarkets™. The growth of this market can be attributed to factors such as the is government investments for cell-based research, rising growth in pharmaceutical & biotechnology industries, increasing cancer
Autoinjectors Market worth $104.9 billion by 2025 - Exclusive Report by MarketsandMarkets™
Autoinjectors Market worth $104.9 billion by 2025 - Exclusive Report by Marketsa …
Autoinjectors Market by Therapy (Rheumatoid Arthritis, Multiple Sclerosis, Anaphylaxis, Cardiovascular Diseases, Diabetes), Type (Disposable, Reusable), Route of administration (Subcutaneous, Intramuscular), End User (Hospital) - Global Forecast to 2025", published by MarketsandMarkets™, the Autoinjectors Market is projected to reach USD 104.9 billion by 2025 from USD 46.0 billion in 2020, at a CAGR of 17.9% from 2020 to 2025. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=173991724&utm_source=Openpr&utm_campaign=Paid&utm_content=Referral Browse in-depth TOC on "Autoinjectors Market" 99 - Tables 55 - Figures 180
Cell Therapy Technologies Market Poised for Remarkable Growth, $7.8 Billion Expected by 2028
Cell Therapy Technologies Market Poised for Remarkable Growth, $7.8 Billion Expe …
Cell Therapy Overview: Cell therapy is a rapidly evolving field in regenerative medicine that involves the use of living cells to treat various medical conditions and diseases. These therapies can be categorized into two main types: autologous (using a patient's own cells) and allogeneic (using cells from a donor). Cell therapy holds great promise for treating a wide range of conditions, including cancer, autoimmune diseases, neurological disorders, and more. The cell therapy

All 5 Releases


More Releases for Nuclear

Nuclear Reactor Market - Crucial business trends 2025 | FirstEnergy Nuclear Gene …
Global Nuclear Reactor Market: Snapshot The global market for nuclear reactors is likely to take significant strides, thanks to the growing need for emission-free energy generation systems over the globe. The emergence of new nuclear power plants has also been responsible for the progress of the worldwide nuclear reactor market. In June 2017, for example, Russia announced that it was in advanced stages of constructing the world’s first ever ‘floating’
Nuclear Reactor Market
Construction of new nuclear across the globe is one of the primary reasons behind the accelerating growth of the global nuclear reactor market, states TMR Research in a new research report. The report is titled, “Nuclear Reactor Market – Global Industry Analysis, Size, Share, Trends, Analysis, Growth, and Forecast 2017 – 2025.” Click on the link below to request a sample copy of the report https://www.tmrresearch.com/sample/sample?flag=B&rep_id=335 The worldwide market for nuclear reactors is
Nuclear Reactor Market - Promising growth opportunities 2025 | FirstEnergy Nucle …
Global Nuclear Reactor Market: Snapshot The global market for nuclear reactors is likely to take significant strides, thanks to the growing need for emission-free energy generation systems over the globe. The emergence of new nuclear power plants has also been responsible for the progress of the worldwide nuclear reactor market. In June 2017, for example, Russia announced that it was in advanced stages of constructing the world’s first ever ‘floating’
Nuclear Energy Industry Analysis of Nuclear Fuels Market 2017-2021
Nuclear fuel is a substance used to initiate and sustain a nuclear fission reaction in nuclear power stations to generate heat. This heat powers turbine to produce usable electrical energy. A nuclear reactor is a structure in which fissile material undergoes a controlled, self-sustaining nuclear reaction with simultaneous release of energy, which can be used to generate electricity. . . – Get Sample Report_https://www.researchmoz.us/enquiry.php?type=S&repid=1069449 ' ' Global nuclear fuels market to grow
Nuclear Power Plant Equipment Market Report 2017- Alstom, Korea Hydro & Nuclear …
Apex Research, recently published a detailed market research study focused on the "Nuclear Power Plant Equipment Market" across the global, regional and country level. The report provides 360° analysis of "Nuclear Power Plant Equipment Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Nuclear Power Plant Equipment industry, and estimates the future
UAE Nuclear Power Sector UAE Nuclear Power Sales Report
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. UAE Power Sector Scenario 1.1 Existing Power Generation Outlook 1.2 Current & Projected Power Demand 2. Why UAE Energy Policy beyond Oil & Gas? 3. UAE Nuclear Power Sector Overview 3.1 UAE Entering into Nuclear Power Sector 3.2 Nuclear Policy Overview 4. UAE Nuclear Power Sector Dynamics 4.1 Favorable Parameters 4.2 Nuclear Power Sector